Is DL a clown or just a D bag - which is it?

anonymous

Guest
Only been here a year and this guy is a clown and a D bag. Not even close to the real caliber of a CFO. He may be the most negative- non trusting-demotivating person I’ve ever met. Why is he here? What does Jeff see in this guy? Help me out! What do you think about DL?
 




My girlfriend works at Goldman and knew him. She told me he is a major D Bag. Would stab and step on anyone to advance. Execs at Goldman figured him out and ran his ass out of there. I thought the guy was sketchy the first time I heard him on a company call. Wanted to impress us with his wall street lingo. He sucks. Just look at the stock price
 
















this place is a HUGE disappointment. leadership owns it all with the poor decisions that mount up every month. they wanted to earn a quick buck with a company flip. now they are in quicksand
 




this place is a HUGE disappointment. leadership owns it all with the poor decisions that mount up every month. they wanted to earn a quick buck with a company flip. now they are in quicksand

feel the same. I put a lot of this on Dan. this is what happens when people in key roles are new to the job and have no experience. sooner Jeff gets rid of that guy the better the company will be. Just hope it is not too late.
 








Wow, serious hate for Dan out there. Don’t really know the guy. He creeped me out at the launch meeting. Felt like he was hitting on me. I do remember on a company call he was asked about our stock and he rambled on forever about crypto currency. I think he is just a weirdo.
 




They like to highlight the decline in the market as the driver of the decline for our stock price. Its not really the current market, its WE HAVE NO NET PROFIT!!! Showing how many doctors wrote an Rx is minimal in terms of value.
 




They like to highlight the decline in the market as the driver of the decline for our stock price. Its not really the current market, its WE HAVE NO NET PROFIT!!! Showing how many doctors wrote an Rx is minimal in terms of value.

is this your first time launching a drug? Launch drugs are all about number of scripts and writers, not net profit. In fact most new drugs don’t break even for several years before they can show net profit. ROOKIE!
 




Hey Kool-Aid drinker. That is totally incorrect. No one cares how many people write the drug if it’s not making any money. It’s a way to try to temporarily elevate the business Showing just utilization. What it comes down to is the balance sheet and if you have no profit no one cares.

It’s obvious the goal here is hey, look how many doctors want to use the product it’s not profitable yet and 90 percent of our Rxs are through BRIDGE aka free……but if one of you big companies come and scoop us up and put major resources behind it for coverage look what this drug can do. buy me buy me buy me! good luck with that. When you’re giving it away you expect to see major uptake and adoption by the medical community iff the product has close to a blockbuster potential. Guess what, that aint us
 








Number of Script that are paid for. When they give away free pigs in the blanket at Costco does everybody rush to go by the box? I don’t think so idiot.
200w.gif
 




Hey Kool-Aid drinker. That is totally incorrect. No one cares how many people write the drug if it’s not making any money. It’s a way to try to temporarily elevate the business Showing just utilization. What it comes down to is the balance sheet and if you have no profit no one cares.

It’s obvious the goal here is hey, look how many doctors want to use the product it’s not profitable yet and 90 percent of our Rxs are through BRIDGE aka free……but if one of you big companies come and scoop us up and put major resources behind it for coverage look what this drug can do. buy me buy me buy me! good luck with that. When you’re giving it away you expect to see major uptake and adoption by the medical community iff the product has close to a blockbuster potential. Guess what, that aint us

WRONG again - why the hell do you think there is such a thing as “break even Point”? No one expects a new drug to be profitable for several years (aka break even Point). Name one FDA approved drug that was profitable in its first year of launch? I’ll wait
 




WRONG again - why the hell do you think there is such a thing as “break even Point”? No one expects a new drug to be profitable for several years (aka break even Point). Name one FDA approved drug that was profitable in its first year of launch? I’ll wait

hey dopey you are misunderstanding the point and big picture. you are giving away free product for the most part and still have flat to minimal growth with minimal money coming in

yes the product isnt profitable which is expected but isn’t driving in any REVENUE. MONEY. CASH. that is what I am getting at, that is what matters. do you think sales will increase when the bridge program goes away?? Are our customers loving the drug so much that they’re generating a ton of prior authorizations?

lets do a comparison in 2021 the Eyesuvis duck did 11.2 million. For CEQUA that puppy did 60 million. Where will we shake out 2022? To date what was Tyrvaya sales? Time will only tell but here are 2 benchmarks we can compare ourselves to. For the record both are noted to be a failure. Lets hear the number of ecps who have written again. it always makes me smile.
 




hey dopey you are misunderstanding the point and big picture. you are giving away free product for the most part and still have flat to minimal growth with minimal money coming in

yes the product isnt profitable which is expected but isn’t driving in any REVENUE. MONEY. CASH. that is what I am getting at, that is what matters. do you think sales will increase when the bridge program goes away?? Are our customers loving the drug so much that they’re generating a ton of prior authorizations?

lets do a comparison in 2021 the Eyesuvis duck did 11.2 million. For CEQUA that puppy did 60 million. Where will we shake out 2022? To date what was Tyrvaya sales? Time will only tell but here are 2 benchmarks we can compare ourselves to. For the record both are noted to be a failure. Lets hear the number of ecps who have written again. it always makes me smile.

clear asshat from NVS. Go back to your hole - I mean cubicle
 




Hey D Bag - I heard you are the CFO and the chief business officer?? What the hell is that? No wonder so much has gone wrong. not bad enough the you f-up the finances but just for fun you are over the entire business to f-up it too? Lets review your resume, your entire experience is screwing up Goldmans healthcare investments so bad that they run your ass out of there and that qualifies you to run a Pharma company? How’s that working out? You IPO at $16 it runs to $40 and down spiral ever since. Can’t manage a budget to keep the company going and you are over the finances and the business? This is why you don’t hire Wall Street rejects to run a Pharma company.
 




hey dopey you are misunderstanding the point and big picture. you are giving away free product for the most part and still have flat to minimal growth with minimal money coming in

yes the product isnt profitable which is expected but isn’t driving in any REVENUE. MONEY. CASH. that is what I am getting at, that is what matters. do you think sales will increase when the bridge program goes away?? Are our customers loving the drug so much that they’re generating a ton of prior authorizations?

lets do a comparison in 2021 the Eyesuvis duck did 11.2 million. For CEQUA that puppy did 60 million. Where will we shake out 2022? To date what was Tyrvaya sales? Time will only tell but here are 2 benchmarks we can compare ourselves to. For the record both are noted to be a failure. Lets hear the number of ecps who have written again. it always makes me smile.

must be D Bag Dan posting this garbage.